About
Contact & Profiles
A5070095551
Research Areas
- Immunotherapy and Immune Responses
- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
CureVac (Germany)
2022
Immunotherapy has revolutionized cancer treatment in recent years. Although currently approved checkpoint inhibitors (CPIs) yield remarkable anti-tumoral responses several types, a substantial proportion of patients do not benefit from such therapies. Local activation innate immune signaling pathways is promising approach to overcome the immunosuppressive tumor microenvironment, induce anti-tumor immunity, and improve efficacy CPI Here, we assessed mode action RNA-based stimulator CV8102 for...
10.1007/s00262-022-03311-4
article
EN
cc-by
Cancer Immunology Immunotherapy
2022-11-02
Coming Soon ...